MYCO:CSE, Mydecine Innovations Group Inc.

MYCO stock overview

Mydecine Innovations Group Inc. (MYCO:CSE) closed at $0.330 on January 30, 2026, unchanged on the day. Mydecine Innovations Group Inc. is part of the Diversified Industries sector.

Key figures

Price
$0.330
Day change
0.00%
Volume
0
Average volume
1,191
Market cap
407K+
52-week range
–
50-day average
$0.286
200-day average
$0.324

Price action over the past year

In 252 trading sessions since November 11, 2025, MYCO closed higher on 12 days (5%). Its best day was February 9, 2026 (+88.57%) and its worst was February 4, 2026 (-46.97%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 6 times.

About Mydecine Innovations Group Inc.

Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.

Similar stocks

Find more stocks like MYCO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.